Click on headlines below to download research
Dentsu has had a strong Q222, reporting organic revenue growth of 8.2% (7.9% including Russia). Customer Transformation & Technology (CT&T) is the main…
Following sustained positive effects from the SAHARA I study in restoring diuretic response (DR) in heart failure (HF) patients with persistent congestion,…
VolitionRx is a clinical diagnostics company with a different perspective on immunoassay technology for the detection and monitoring of severe diseases…
The long and frustrating wait for the EU directive on whistleblowing to be passed into law in Germany should finally end in late September and we would…
Context Therapeutics’ Q222 results provided an update on the company’s operating performance and pipeline. Operating losses of $4.0m, increased…
OpGen’s Q222 revenue growth re-accelerated with the post-pandemic normalization in demand. Revenues of $0.97m increased 19% y-o-y, largely driven…
Mirriad’s interim results confirm the trading update published in July, which indicated the impact of the withdrawal from China, and we make no further…
JDC Group (JDC) reported strong Q222 numbers and reiterated its FY22 guidance for revenues of €165.0–175.0m (FY21: €146.8m) and EBITDA…
S&U’s lending growth has been ahead of expectations in H123, despite relatively weak consumer confidence and a conservative underwriting policy.…
H1 revenue grew 3% against tough comparators and operating profit increased by 13% y-o-y, reflecting good underlying markets and M&A in lettings. The announcement…
Despite a challenging market environment, Checkit has grown annualised recurring revenue (ARR) by 48% y-o-y to £10.2m at the end of H123 and looks…
As expected, Primary Health Properties (PHP) reported a strong financial and operational performance in H122 and is well into its 26th year of unbroken…
Following strong Q222 results, SIGA Technologies has announced that the Biomedical Advanced Research and Development Authority (BARDA) has exercised its…
We consider CoinShares International (CS) an attractively priced option on the prospective adoption of digital assets. We estimate that CS’s market…
Endeavour’s Q222 results were better than our expectations. Production for the quarter was 345koz (cf our expectation of 322koz) at an all-in sustaining…
4imprint’s first half results show the benefit of record levels of customer demand, with revenue up 58% year-on-year and operating profit rising…
Basilea Pharmaceutica is a Switzerland-based biopharmaceutical company, established in 2000 as a spin-out from Roche with the divestment of its anti-infective…
Claranova has reported Q422/FY22 revenue substantially in line with our forecast. The group reported revenue growth of 4% for Q422 and 1% for FY22. As…
paragon has spent much of the pandemic refocusing on its core automotive activities and addressing the issue of bond refinancing. Both are now largely…
SynBiotic has extended its lead in the European hemp and cannabis sector and is continuing to build a cannabis ‘ecosystem’, encompassing cultivation,…
Tinexta’s interim results were strong due to a combination of underlying growth and contributions from M&A. The completion of the disposal of its…
TEST SUMMARY TEXT
Steakholder Foods, formerly MeaTech 3D, is an international deep-tech food company at the forefront of the cultured meat revolution. It began activities…
Agronomics (ANIC) invests in cellular agriculture companies. This report provides an update on our January 2022 initiation note and March 2022 update,…
Endeavour’s Q222 results were better than our expectations. Production for the quarter was 345koz (cf our expectation of 322koz) at an all-in sustaining…
YouGov’s year-end trading update (to end-July) indicates results in line with management expectations, with underlying growth across all segments…
Abrdn Private Equity Opportunities Trust (APEO) posted a 6.8% NAV total return (TR) in H122 (ending March 2022), which was a function of a robust return…
In an increasingly challenging environment, Phoenix Spree Deutschland (PSDL) has reported ongoing growth in rents and portfolio values for H122. Demographic…
Fidelity Emerging Markets (FEML) was transferred to Fidelity in October 2021. FEML mirrors the FAST EM Fund (FAST, £178m AUM at 30 June 2022), which…
Kazia Therapeutics has reported that the company’s lead asset paxalisib (PI3K/mTOR inhibitor) has not graduated to Stage 2 of the Phase III GBM AGILE…
SIGA reported strong Q222 results driven by international expansion and rapid response to the larger than-expected monkeypox outbreak. Q222 product sales…
Carr’s Group’s trading update for the 22 weeks ending 30 July 2022 notes that the overall trading performance for FY22 is in line with board…
Incannex Healthcare, an Australian cannabinoid and psychedelic medicines biotech, has announced that it has completed the acquisition of APIRx Pharmaceuticals…
Lepidico is awaiting the delivery of Phase 1 control estimates from its EPCM contractor ahead of making a final investment decision (FID) on its Karibib…
CLIQ Digital’s H122 results were strong across all KPIs, illustrating that the group is on track to reach management’s FY22 guidance, which…
In this interview, CIO of Allianz Global Investors, Simon Gergel, highlights what the Merchants Trust (MRCH) offers investors in terms of both capital…
Baker Steel Resources Trust (BSRT) recently faced headwinds from weaker equity and industrial/precious metals markets and the impact of cost inflation…
With its FY22 results at the end of June, Accsys provided guidance for FY23 to almost double EBITDA, mainly driven by new capacity. To fulfil the strong…
The Merchants Trust (MRCH) is actively managed by Allianz Global Investors’ highly experienced chief investment officer of UK equities/UK income,…
Pixium has received regulatory approval in multiple countries (France, Germany, Italy, Spain and the Netherlands) for its remote rehabilitation system,…
Watch this Edison interview with Loop Energy CEO Ben Nyland, following the company’s Q222 earnings release on 3 August. Ben highlights a record quarter…
Greggs’ (GRG) strong H122 results and trading to July demonstrate the resilience of its value-based product offering to customers in more challenging…
IP Group has released its H122 interim results, which are in line with guidance given at the end of May. They show an NAV per share of 136.7p, an 18% fall…
Creo Medical announced its H122 trading update ahead of full interim results in September. H122 revenue was around £13.5m, a c 5% y-o-y increase compared…
Test - ignore
This is a test. Type five lines to get your key investment message across here. Explain to the investor why this company has a strong product or service…
So far in 2022 long-duration growth stocks have seen a significant de-rating due to a variety of reasons such as the war in Ukraine, supply chain issues…
Context Therapeutics announced plans to collaborate with the Menarini Group to study ONA-XR in combination with elacestrant, an oral selective estrogen…
Medlab Clinical has released its cash flow report for Q422 and the full FY22 period. Net cash outflow from operating activities in FY22 was A$9.0m, roughly…
Filtronic’s FY22 results show revenues growing by 10% while adjusted EBITDA jumped by 58% despite the challenges posed by global supply chain shortages.…
Sylvania Platinum is a safe, low-cost surface platinum group metals (PGM) dump re-treatment company operating in South Africa (SA). Its low-cost operations…
In this interview, CEO Gavin Griggs and CFO Oskar Zahn discuss XP Power’s H122 results. They explain the challenges the company faced during the…
Cohort’s position as a growing international defence company is being increasingly recognised as the sector gains relevance for governments and investors…
Mytilineos reported record-high H122 results. Net profit after minorities increased by 116% to €166m, versus H121 (€77m) and was higher than…
Respiri has announced that, along with partner Access Telehealth, it has successfully concluded a system integration of the companies’ platforms…
Ahead of its FY22 results, Arovella has released its quarterly activities report, reiterating key developments and milestones achieved in the closing quarter…
The continuation of component shortages and further COVID-19 disruption reduced the amount of product XP Power could ship in H122, weighing on gross margins…
The Law Debenture Corporation (LWDB) has reported on a robust first six months of 2022. The NAV total return was negative but ahead of the benchmark and…
In Q123, discoverIE saw a continuation of the strong organic growth reported in FY22, with revenue 17% higher y-o-y on an organic basis and 27% higher…
Sareum has announced that it has filed a clinical trial authorisation (CTA) application for its lead asset, SDC-1801, with the UK Medicines and Healthcare…
As a regionally focused specialist asset manager, Mercia does not expect to experience the same highs and lows in valuations seen in more international…
Else raised gross proceeds of C$7.35m through equity. It offered 7.004m units at C$1.05, with each unit consisting of one share and one warrant. The warrants…
Solid State delivered record revenues and profits during FY22, with adjusted EPS rising by 29% year-on-year to 70.6p. This is well ahead of management’s…
VietNam Holding (VNH), managed by Dynam Capital (Dynam), a Vietnamese equities closed-ended fund, has given away some of its performance gains of the past…
GB Group’s AGM trading update confirms that the Fraud and Location businesses have seen solid underlying growth year-to-date. A tough comparative…
musicMagpie’s (MMAG) headline H122 figures were well flagged in the June 2022 trading update, with profitability and cash flow driven by the changing…
AFT Pharmaceuticals announced that its Pascomer Phase II clinical trial has failed to meet its primary endpoint of a two-point improvement on the Investigator’s…
Quadrise has signed a framework agreement with MSC Shipmanagement that covers proof-of-concept (POC) tests and subsequent letters of no objection (LONO)…
Ergomed’s H122 trading update re-emphasised its robust business model and resilient growth despite the challenging macro environment. Revenues grew…
OpGen’s subsidiary, Ares Genetics, has signed a research collaboration agreement with the Belgian National Reference Center (BNRC) for invasive Streptococcus…
Diurnal announced a trading update for the 12-month period ending June 2022, reporting top-line results broadly in line with consensus estimates. While…
For the three months to 30 June (Q123), Picton Property Income has continued to generate attractive total returns, including valuation gains across each…
Pixium has entered into a convertible notes financing arrangement with US-based healthcare investor European Select Growth Opportunities Fund (ESGO), for…
Wheaton Precious Metals’ (WPM’s) Q222 results are scheduled for release after the market close in North America on 11 August. This note reduces…
Mirriad’s decision to exit the Chinese market, following weaker than expected trading and restructuring of the Tencent contract, is a clear setback…
While currency headwinds reduced growth on a reported basis in H122, Boku expects to report constant currency growth of 14% for total payment volume (TPV)…
Oryzon Genomics has announced that it is has entered into a partnership with the Charcot-Marie-Tooth Research Foundation (CMTRF). The collaboration will…
On 23 July the World Health Organization (WHO) declared monkeypox a global health emergency (only the seventh since 2009). With the anticipated worldwide…
Following the exits of Marmalade and EVRYTHNG in 2021, Bloc’s FY21 NAV/share rose 7% y-o-y to £25.30. Bloc has now delivered a FY18–21…
Pan American Silver (PAAS) has announced the results of additional infill and exploration drilling at the La Colorada Skarn project. The latest data are…
Oryzon Genomics has reported results for H122 and highlighted the progress of key assets iadademstat and vafidemstat during the period. It reported combined…
Recent engagement with the Central Bank of Ireland (CBI) has confirmed that EML Payments’ Irish subsidiary will need to undertake further work to…
SenSen continued its run of record quarterly cash receipts, which rose 128% y-o-y and 117% q-o-q to A$3.7m. Notably, the company secured contracts worth…
Shield Therapeutics’ (STX) value stems from Accrufer’s US market opportunity as the company seeks to maximise returns through self-commercialisation.…
Worldwide Healthcare Trust (WWH) has two co-managers, Sven Borho and Trevor Polischuk at global healthcare specialist OrbiMed. Borho recently presented…
Nicox’s Q222 update confirms its overall business plan and its expectation that primary efficacy data for the Mont Blanc Phase III study of lead…
JPMorgan European Discovery Trust (JEDT) specialises in continental European small and mid-caps. The strength of the strategy is that while it is actively…
CentralNic has delivered another record quarter, with pro forma last 12 months organic revenue growth of 62% to 30 June 2022 (53% to 31 March 2022), driven…
We believe that Norcros’s proven strategy remains on track, which should allow it to unlock significant market growth opportunities. We also believe…
Renewi is a leader in its chosen waste and recycling sectors and well positioned in the emerging circular economy. The shares trade at a discount to peers…
Centaur has posted good H122 figures, with revenues ahead by 8% on H121 and an uplift in EBITDA margin from 12% to 17%, well on the way to achieving the…
1Spatial has announced a sizeable contract with a major European aerospace company worth circa €3m over five years. Notably, the deal is the first…
Sequana Medical provided an update following encouraging data from its Phase IIa SAHARA Direct Sodium Removal (DSR) study in patients with persistent congestion…